Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nonalcoholic fatty liver disease shows significant sex dimorphism
Xingyu Chen, Cong Wang, Yizhou Huang, et al.
World Journal of Clinical Cases (2022) Vol. 10, Iss. 5, pp. 1457-1472
Open Access | Times Cited: 22

Showing 22 citing articles:

Cuproptosis Cell Death Molecular Events and Pathways to Liver Disease
Yun Mao, Huilan Chen, Weihan Zhu, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 883-894
Open Access | Times Cited: 2
Estrogen-dependent activation of TRX2 reverses oxidative stress and metabolic dysfunction associated with steatotic disease
Alfredo Smiriglia, Nicla Lorito, Marina Bacci, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
The Ability of the Triglyceride-Glucose (TyG) Index and Modified TyG Indexes to Predict the Presence of Metabolic-Associated Fatty Liver Disease and Metabolic Syndrome in a Pediatric Population with Obesity
Sofia Tamini, Adele Bondesan, Diana Caroli, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2341-2341
Open Access | Times Cited: 1
MASLD: Prevalence, Mechanisms, and Sex-Based Therapies in Postmenopausal Women
Ilaria Milani, Marianna Chinucci, Frida Leonetti, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 855-855
Open Access | Times Cited: 1
Protective effects of the succinate/SUCNR1 axis on damaged hepatocytes in NAFLD
Anna Marsal-Beltran, Adrià Rodríguez-Castellano, Brenno Astiarraga, et al.
Metabolism (2023) Vol. 145, pp. 155630-155630
Open Access | Times Cited: 20
Effect of Intermittent Fasting on Lipid Profile, Anthropometric and Hepatic Markers in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review
María Fernanda Castillo, Daniela Salgado-Canales, Marco Arrese, et al.
Current Vascular Pharmacology (2024) Vol. 22, Iss. 3, pp. 187-202
Closed Access | Times Cited: 5
Genetic Polymorphisms and Diversity in Nonalcoholic Fatty Liver Disease (NAFLD): A Mini Review
Siti Aishah Sulaiman, Vicneswarry Dorairaj, Muhammad Nafiz Haidi Adrus
Biomedicines (2022) Vol. 11, Iss. 1, pp. 106-106
Open Access | Times Cited: 20
Protective effects of baicalin magnesium on non-alcoholic steatohepatitis rats are based on inhibiting NLRP3/Caspase-1/IL-1β signaling pathway
Xiulu Guan, Shiyuan Shen, Jinxia Liu, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Steatotic liver disease induced by TCPOBOP-activated hepatic constitutive androstane receptor: primary and secondary gene responses with links to disease progression
Ravi Sonkar, Hong Ma, David J. Waxman
Toxicological Sciences (2024) Vol. 200, Iss. 2, pp. 324-345
Open Access | Times Cited: 2
Evidence That Peripheral Leptin Resistance in Omental Adipose Tissue and Liver Correlates with MASLD in Humans
Lucía De la Cruz-Color, José Alfredo Domı́nguez-Rosales, Montserrat Maldonado‐González, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6420-6420
Open Access | Times Cited: 2
High-Sensitivity C-Reactive Protein Levels in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic Alcohol-Associated Liver Disease (MetALD), and Alcoholic Liver Disease (ALD) with Metabolic Dysfunction
Seong‐Uk Baek, Jin‐Ha Yoon
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1468-1468
Open Access | Times Cited: 1
Steatotic liver disease induced by TCPOBOP-activated hepatic constitutive androstane receptor: Primary and secondary gene responses with links to disease progression
Ravi Sonkar, Hong Ma, David J. Waxman
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Contribution of Sex Differences to Development of Cardiovascular Disease in Metabolic-Associated Steatotic Liver Disease (MASLD)
Lucy C. Taylor, Gertrude Arthur, Miguel Cruz, et al.
International Journal of Translational Medicine (2024) Vol. 4, Iss. 4, pp. 782-809
Open Access | Times Cited: 1
Current status of disparity in liver disease
Tomoki Sempokuya, Josh Warner, Muaataz Azawi, et al.
World Journal of Hepatology (2022) Vol. 14, Iss. 11, pp. 1940-1952
Open Access | Times Cited: 6
Epidemiology of lean/non-obese nonalcoholic fatty liver disease in China
Jianmei Zhang, Xiaocheng Huang, Luying Dong, et al.
Saudi Medical Journal (2023) Vol. 44, Iss. 9, pp. 848-863
Open Access | Times Cited: 3
Gender Dimorphism in Hepatic Carcinogenesis-Related Gene Expression Associated with Obesity as a Low-Grade Chronic Inflammatory Disease
Andrea G. Izquierdo, Marcos C. Carreira, Gemma Rodríguez-Carnero, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15002-15002
Open Access | Times Cited: 4
Increased detection rates of advanced colorectal adenoma in women with metabolic dysfunction-associated fatty liver disease
Yan Gong, Juan Kang, Xinyan Wang, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e22391-e22391
Open Access | Times Cited: 2
Association of sex-specific body mass index and waist circumference trajectories with non-alcoholic fatty liver disease incidence based on growth mixture modeling
Tengrui Cao, Chao Tong, Qiang Li, et al.
Nutrition Metabolism and Cardiovascular Diseases (2024) Vol. 34, Iss. 5, pp. 1245-1256
Closed Access
Estrogen-dependent TRX2 activation reverts oxidative stress and metabolic dysfunction associated to steatotic disease
Andrea Morandi, Alfredo Smiriglia, Nicla Lorito, et al.
Research Square (Research Square) (2024)
Open Access
Evaluating the relative importance of different blood pressure indices in screening for NAFLD: a survey report based on a health examination population
Chong Hu, Ziqi Yu, Changli Wei, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access
Development of a Novel four-gene Model for Monitoring the Progression from Metabolic Dysfunction-associated Steatotic Liver Disease to Hepatocellular Carcinoma in Males
Yuchuan Jiang, Jiejian Chen, Lin Xu, et al.
Journal of Cancer (2024) Vol. 16, Iss. 3, pp. 917-931
Open Access
Neonatal administration of fenofibrate had no developmental programming effect on the lipid profile and relative leucocyte telomere lengths of adolescent rats fed a high-fructose diet postnatally
Kasimu Ghandi Ibrahim, Eliton Chivandi, Kennedy H. Erlwanger, et al.
Canadian Journal of Physiology and Pharmacology (2023) Vol. 101, Iss. 11, pp. 565-573
Closed Access
Page 1

Scroll to top